iPS cell-derived mesenchymal stem cells have powerful immunoregulatory and regenerative properties

Nearly 100 clinical INDs of stem cell drugs have been approved in my country! In 2024, my country will add 20 new stem cell products, 17 of which are mesenchymal stem cells

INDs approved for 9 domestic CGT therapies (September 2024)

Seven gene therapies in China have been approved for IND, and the research and development momentum is strong

Major breakthrough in stem cells: The University of Hong Kong School of Medicine develops a shortcut to neural stem cells to reverse the treatment dilemma of aging-related diseases